Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

NCT03211858 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

597

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin aspart
DRUG: NovoLog/NovoRapid
DRUG: Insulin glargine (HOE901)

Sponsor

Sanofi